NM_001330588.2:c.108G>A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_001330588.2(TPP2):c.108G>A(p.Arg36Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000481 in 1,456,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000048 ( 0 hom. )
Consequence
TPP2
NM_001330588.2 synonymous
NM_001330588.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.31
Publications
0 publications found
Genes affected
TPP2 (HGNC:12016): (tripeptidyl peptidase 2) This gene encodes a mammalian peptidase that, at neutral pH, removes tripeptides from the N terminus of longer peptides. The protein has a specialized function that is essential for some MHC class I antigen presentation. The protein is a high molecular mass serine exopeptidase; the amino acid sequence surrounding the serine residue at the active site is similar to the peptidases of the subtilisin class rather than the trypsin class. [provided by RefSeq, Jul 2008]
TPP2 Gene-Disease associations (from GenCC):
- immunodeficiency 78 with autoimmunity and developmental delayInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 13-102597146-G-A is Benign according to our data. Variant chr13-102597146-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3672077.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.31 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000481 AC: 7AN: 1456734Hom.: 0 Cov.: 31 AF XY: 0.00000414 AC XY: 3AN XY: 724594 show subpopulations
GnomAD4 exome
AF:
AC:
7
AN:
1456734
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
724594
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33106
American (AMR)
AF:
AC:
0
AN:
44526
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25954
East Asian (EAS)
AF:
AC:
0
AN:
39456
South Asian (SAS)
AF:
AC:
0
AN:
85736
European-Finnish (FIN)
AF:
AC:
0
AN:
52750
Middle Eastern (MID)
AF:
AC:
0
AN:
4742
European-Non Finnish (NFE)
AF:
AC:
7
AN:
1110410
Other (OTH)
AF:
AC:
0
AN:
60054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency Benign:1
May 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.